US EditionPublished • loading... • Updated
Trump administration suggests Tylenol during pregnancy causes autism
- President Donald Trump announced in a White House statement on Monday that Tylenol may cause autism, suggesting a mass withdrawal from the drug.
- The announcement followed longstanding legal and public debates over Tylenol’s safety, with a 2024 landmark study largely debunking a connection between acetaminophen and autism.
- Kenvue, Tylenol’s manufacturer since its 2023 spin-off from Johnson & Johnson, strongly denied the claim, citing “sound science” that acetaminophen does not cause autism.
- Shares of Kenvue dropped 7.5% Monday, reducing market value by about $2.6 billion, continuing a 25% decline over six months amid growing public skepticism about Tylenol’s safety.
- The controversy highlights ongoing tensions between political claims and scientific evidence, while experts and analysts debate potential impacts on public health and Kenvue’s business.
Insights by Ground AI
481 Articles
481 Articles
President Trump warning pregnant women against Tylenol, claiming medicine is linked to rise in autism
President Trump says bottles of Tylenol will carry an additional warning label for expecting mothers, stating that if you take acetaminophen, your child could be at risk for autism.
·Connecticut, United States
Read Full Article
Coverage Details
Total News Sources481
Leaning Left105Leaning Right55Center167Last UpdatedBias Distribution51% Center
Bias Distribution
- 51% of the sources are Center
51% Center
L 32%
C 51%
R 17%
Factuality
To view factuality data please Upgrade to Premium
